Compare ECO & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ECO | INSP |
|---|---|---|
| Founded | 2018 | 2007 |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.7B |
| IPO Year | 2023 | 2018 |
| Metric | ECO | INSP |
|---|---|---|
| Price | $76.15 | $73.00 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 16 |
| Target Price | $42.00 | ★ $94.00 |
| AVG Volume (30 Days) | ★ 483.2K | 425.4K |
| Earning Date | 05-13-2026 | 05-04-2026 |
| Dividend Yield | ★ 6.12% | N/A |
| EPS Growth | N/A | ★ 179.43 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $82,050,000.00 |
| Revenue This Year | $16.07 | $8.02 |
| Revenue Next Year | N/A | $8.11 |
| P/E Ratio | $18.60 | ★ N/A |
| Revenue Growth | N/A | ★ 62.18 |
| 52 Week Low | $27.74 | $38.91 |
| 52 Week High | $72.75 | $147.03 |
| Indicator | ECO | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 71.01 | 68.85 |
| Support Level | $48.27 | $56.50 |
| Resistance Level | N/A | $86.00 |
| Average True Range (ATR) | 1.95 | 2.77 |
| MACD | 0.45 | 0.15 |
| Stochastic Oscillator | 96.37 | 84.66 |
Okeanis Eco Tankers Corp is an international owner and operator of a fleet of tanker vessels used for the transportation of crude oil. Its fleet consists of modern Suezmax and VLCC tankers that are designed in accordance with eco-efficiency standards, including features such as reduced fuel consumption, exhaust gas cleaning systems, and ballast water treatment systems. All of the company's revenue is derived from a single segment, the crude oil tanker segment. Geographically, the maximum revenue is generated from Europe, and the rest from Asia, North America, and South America.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.